Program Overview The Translational Research Skills Development Core will be directed by Dr. Kenneth Bauer. The goal of this program is to train physicians with a major interest in blood coagulation and vascular biology. The program will integrate formal didactic training, research skills development, and close mentorship by experienced faculty to facilitate the transition of senior fellows to junior faculty and independent investigators. A particular focus will be on training candidates to conduct patient-oriented research in the field of hemostasis and thrombosis. The program is targeted at junior clinician scientists to foster their transition from senior fellows or entry-level faculty to independently funded investigators. Without programs for protecting a physician's time to conduct research and gain further training, this can be a particularly vulnerable period for physician trainees. This program will provide two years of 75% salary support, which will afford senior fellows or junior faculty sufficient protected time to generate the data required for a competitive NIH application (e.g., K23 mentored physician scientist or a first R01). This program will facilitate the development of three junior faculty over five years (the award will be for one year of support in year 5 of this grant). Enrollment into the program will be open to physicians with an interest in clinical research in hemostasis and thrombosis within the Divisions of Hematology-Oncology, Hemostasis-Thrombosis, Cardiology, or Pulmonary and Critical Care Medicine at Beth Israel Deaconess Medical Center or from similar programs at Harvard affiliated hospitals e.g. Childrens Hospital Boston. Eligibility will require a faculty appointment with institutional support for the remaining 25% effort.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZHL1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Beth Israel Deaconess Medical Center
United States
Zip Code
Bowley, Sheryl R; Fang, Chao; Merrill-Skoloff, Glenn et al. (2017) Protein disulfide isomerase secretion following vascular injury initiates a regulatory pathway for thrombus formation. Nat Commun 8:14151
Stopa, Jack D; Baker, Katherine M; Grover, Steven P et al. (2017) Kinetic-based trapping by intervening sequence variants of the active sites of protein-disulfide isomerase identifies platelet protein substrates. J Biol Chem 292:9063-9074
Stopa, Jack D; Neuberg, Donna; Puligandla, Maneka et al. (2017) Protein disulfide isomerase inhibition blocks thrombin generation in humans by interfering with platelet factor V activation. JCI Insight 2:e89373
Flaumenhaft, R (2016) Probing for thiol isomerase activity in thrombi. J Thromb Haemost 14:1067-9
Galinski, Christine N; Zwicker, Jeffrey I; Kennedy, Daniel R (2016) Revisiting the mechanistic basis of the French Paradox: Red wine inhibits the activity of protein disulfide isomerase in vitro. Thromb Res 137:169-73
Schulman, Sol; Bendapudi, Pavan; Sharda, Anish et al. (2016) Extracellular Thiol Isomerases and Their Role in Thrombus Formation. Antioxid Redox Signal 24:1-15
Flaumenhaft, Robert; Furie, Bruce (2016) Vascular thiol isomerases. Blood 128:893-901
Bekendam, Roelof H; Bendapudi, Pavan K; Lin, Lin et al. (2016) A substrate-driven allosteric switch that enhances PDI catalytic activity. Nat Commun 7:12579
Flaumenhaft, Robert; Furie, Bruce; Zwicker, Jeffrey I (2015) Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease. Arterioscler Thromb Vasc Biol 35:16-23
Sharda, Anish; Kim, Sarah H; Jasuja, Reema et al. (2015) Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome. Blood 125:1633-42

Showing the most recent 10 out of 17 publications